Testing effectiveness (Phase 2)Ended earlyNCT05053035What this trial is testingEvaluate AL001 in C9orf72-Associated ALSWho this might be right forAmyotrophic Lateral Sclerosis Alector Inc. 5
Not applicableLooking for participantsNCT03865420What this trial is testingAmyotrophic Lateral Sclerosis (ALS) Families ProjectWho this might be right forALS Columbia University 300
Early research (Phase 1)Active Not RecruitingNCT07204977What this trial is testingAcamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)Who this might be right forAmyotrophic Lateral SclerosisMotor Neuron Disease National Institute of Neurological Disorders and Stroke (NINDS) 30
Testing effectiveness (Phase 2)Study completedNCT04993755What this trial is testingA Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTDWho this might be right forAmyotrophic Lateral SclerosisFrontotemporal Dementia Transposon Therapeutics, Inc. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04747431What this trial is testingPBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesWho this might be right forFrontotemporal DementiaFTDFTD-GRN+2 more Passage Bio, Inc. 30
Not applicableStudy completedNCT05852405What this trial is testingClinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALSWho this might be right forMotor Neuron Disease, Amyotrophic Lateral Sclerosis Ambulanzpartner Soziotechnologie APST GmbH 2,000
Not applicableLooking for participantsNCT00317616What this trial is testingThe Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) StudyWho this might be right forAmyotrophic Lateral Sclerosis University of Miami 500
Testing effectiveness (Phase 2)Study completedNCT03987295What this trial is testingEvaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)Who this might be right forFrontotemporal Dementia Alector Inc. 33
Not applicableActive Not RecruitingNCT04516499What this trial is testingNeurofilament Surveillance Project (NSP)Who this might be right forFrontotemporal DementiaFrontotemporal Lobar DegenerationFTD-GRN+2 more The Bluefield Project to Cure Frontotemporal Dementia 342
Testing effectiveness (Phase 2)Study completedNCT05163886What this trial is testingStudy of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral SclerosisWho this might be right forAmyotrophic Lateral SclerosisALS OrphAI Therapeutics 14
Not applicableStudy completedNCT04060082What this trial is testingVoices Of Individuals: Challenges and Experiences Of bvFTDWho this might be right forFrontotemporal DementiaFrontotemporal DegenerationFrontotemporal Dementia, Behavioral Variant+1 more University of Pennsylvania 26
Testing effectiveness (Phase 2)Study completedNCT05189106What this trial is testingNeurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket TrialWho this might be right forAmyotrophic Lateral SclerosisAlzheimer DiseaseMild Cognitive Impairment Massachusetts General Hospital 17
Not applicableStudy completedNCT04819555What this trial is testingFrequency of SOD1 and C9orf72 Gene Mutations in French ALSWho this might be right forAmyotrophic Lateral Sclerosis University Hospital, Tours 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04931862What this trial is testingStudy of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)Who this might be right forALSFTD Wave Life Sciences USA, Inc. 35
Not applicableStudy completedNCT01925196What this trial is testingNatural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene MutationWho this might be right forAmyotrophic Lateral SclerosisFrontotemporal Lobar Degeneration National Institute of Neurological Disorders and Stroke (NINDS) 50
Not applicableNo Longer AvailableNCT05483322What this trial is testingAn Open-Label, Expanded Access Protocol of LAM-002A in C9ORF72-Associated Frontotemporal Dementia (FTD)Who this might be right forFrontotemporal Dementia OrphAI Therapeutics
Testing effectiveness (Phase 2)Active Not RecruitingNCT04220021What this trial is testingSafety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTDWho this might be right forC9orf72 Amyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia University of Florida 41
Not applicableLooking for participantsNCT04363684What this trial is testingARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)Who this might be right forFrontotemporal Lobar Degeneration (FTLD)Progressive Supranuclear Palsy (PSP)Corticobasal Degeneration (CBD)+11 more Mayo Clinic 2,100
Not applicableStudy completedNCT02686268What this trial is testingUnderstanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALSWho this might be right forC9ORF72 Amyotrophic Lateral Sclerosis (ALS) Washington University School of Medicine 128
Early research (Phase 1)Ended earlyNCT04288856What this trial is testingStudy to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)Who this might be right forAmyotrophic Lateral Sclerosis Biogen 75